Loading clinical trials...
Loading clinical trials...
The risk of Arterial Hypertension (HTA) is increased in very premature infants and hydrocortisone administered in the neonatal period could modify this risk. The main objective is to assess whether t...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
NCT07216664 · Infant, Premature, Diseases
NCT06335524 · Child Development, Infant Development, and more
NCT06878742 · Infant, Premature, Diseases, Circulatory and Respiratory Physiological Phenomena
NCT05030337 · Infant, Premature, Diseases, Airway Morbidity, and more
NCT06366893 · Infant, Premature, Diseases
Robert Debre Hospital
Paris
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions